Benzinga - Wed, 05 May 2021 07:30:17 -0400
Benzinga - Wed, 05 May 2021 04:15:58 -0400
Benzinga - Tue, 04 May 2021 10:09:11 -0400
Benzinga - Fri, 23 Apr 2021 08:12:42 -0400
Benzinga - Mon, 19 Apr 2021 08:12:07 -0400
Benzinga - Mon, 19 Apr 2021 05:19:22 -0400
Benzinga - Fri, 16 Apr 2021 13:39:27 -0400
Benzinga - Fri, 16 Apr 2021 10:08:04 -0400
load more
Sector: Health Care.Industry: Biotechnology
Editas Medicine Inc is a gene-editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company's only operating segment being developing and commercializing genome editing technology.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-0.750-0.860 -0.1100
REV5.140M6.499M1.359M
Q4 2020Est.ActualSurprise
EPS-0.740-1.000 -0.2600
REV5.640M11.419M5.779M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
EDITEditas Medicine-0.67%2.3B

Editas Medicine Company Questions & Answers

Q

How do I buy Editas Medicine (EDIT) stock?

A

You can purchase shares of Editas Medicine (NASDAQ: EDIT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Editas Medicine's (EDIT) main competitors?

A

Other companies in Editas Medicine’s space includes: Burning Rock Biotech (NASDAQ:BNR), OPKO Health (NASDAQ:OPK) and Xencor (NASDAQ:XNCR).

Q

What is the target price for Editas Medicine?

A

The latest price target for Editas Medicine (NASDAQ: EDIT) was reported by RBC Capital on 2021-05-04. The analyst firm set a price target for 40.00 expecting EDIT to rise to within 12 months (a possible 17.27% upside). 19 analyst firms have reported ratings in the last year.

Q

How much is Editas Medicine (EDIT) stock ?

A

The stock price for Editas Medicine (NASDAQ: EDIT) is $34.11 last updated Fri May 07 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Editas Medicine (EDIT) dividend?

A

There are no upcoming dividends for Editas Medicine.

Q

When is Editas Medicine (NASDAQ:EDIT) reporting earnings?

A
Editas Medicine’s Q2 earnings are confirmed after-market from now on August 5, 2021.
Q

When is the upcoming split for EDIT?

A

There is no upcoming split for Editas Medicine.